Day 1 | PSMA PET, Active Surveillance, ED & Incontinence | 2022 Prostate Cancer Patient Conference

Treatments for Advanced Prostate Cancer in 2022 | Evan Yu, MD | PCRIПодробнее

Active Surveillance of Prostate CancerПодробнее

2021 Prostate Cancer Patient Conference | Day 1Подробнее

PSMA PET and Functional Imaging - 2021 Prostate Cancer Patient ConferenceПодробнее

PSMA PET/CT “live” cases: Pearls and pitfalls - MDT panel @ ProsTIC Preceptorship 2022 previewПодробнее

Active Surveillance in 2022 | Laurence Klotz, MD | PCRIПодробнее

Day 1 | PSMA PET, Active Surveillance, ED & Incontinence | 2022 Prostate Cancer Patient ConferenceПодробнее

How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients Webcast (2023)Подробнее

PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022Подробнее

Active Surveillance, Incontinence & ED, Side Effects, Mark Moyad, MD, MPH & Mark Scholz, MD | Day 1Подробнее

PSMA & Lutetium-177 in 2022 | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 4Подробнее

Prostate Cancer, PSMA PET and Functional ImagingПодробнее

Day 2 | Advanced Treatments, LU-177, Extended Q+A | 2022 Prostate Cancer Patient ConferenceПодробнее

Appropriate Use of PSMA PET in Clinical PracticeПодробнее

Prostate Cancer Realities - 2022 Prostate Cancer Virtual ConferenceПодробнее

Guidelines for using PSMA PET in the staging of prostate cancerПодробнее

14 Years: #ProstateCancer & Active Surveillance | Bill Manning, Director of @aspi2020Подробнее

Active Surveillance Conference Day 1Подробнее

Finding an Oncologist for Advanced Disease | Scanning for Metastases Early | Mark Scholz, MD | PCRIПодробнее

Day 2 #ProstateCancer Active Surveillance, Advanced Treatments, Q&A | PCRI 2023 ConferenceПодробнее

PSMA & Newly-Diagnosed #ProstateCancer | MarkScholzMD #AlexScholz #PCRIПодробнее